

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 9.72716187 |
| 2 | DNA deamination (GO:0045006) | 9.26378909 |
| 3 | T cell migration (GO:0072678) | 7.41951364 |
| 4 | production of molecular mediator involved in inflammatory response (GO:0002532) | 6.76078954 |
| 5 | lymphocyte chemotaxis (GO:0048247) | 6.33092485 |
| 6 | signal complex assembly (GO:0007172) | 5.92626370 |
| 7 | pyrimidine nucleoside catabolic process (GO:0046135) | 5.84400697 |
| 8 | positive regulation of gamma-delta T cell activation (GO:0046645) | 5.37545442 |
| 9 | eosinophil chemotaxis (GO:0048245) | 5.14508927 |
| 10 | negative regulation of viral genome replication (GO:0045071) | 5.12824226 |
| 11 | negative regulation by host of viral transcription (GO:0043922) | 4.79384507 |
| 12 | macrophage chemotaxis (GO:0048246) | 4.78926205 |
| 13 | cellular response to interleukin-15 (GO:0071350) | 4.71969252 |
| 14 | lymphocyte migration (GO:0072676) | 4.71902754 |
| 15 | eosinophil migration (GO:0072677) | 4.64032620 |
| 16 | regulation of gamma-delta T cell differentiation (GO:0045586) | 4.62401963 |
| 17 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.57907500 |
| 18 | granulocyte activation (GO:0036230) | 4.57735173 |
| 19 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 4.44388910 |
| 20 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.40058226 |
| 21 | positive regulation of macrophage differentiation (GO:0045651) | 4.37399630 |
| 22 | response to interleukin-15 (GO:0070672) | 4.34262626 |
| 23 | megakaryocyte development (GO:0035855) | 4.30634928 |
| 24 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 4.24568443 |
| 25 | positive regulation of defense response to virus by host (GO:0002230) | 4.21578625 |
| 26 | positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517) | 4.13648024 |
| 27 | positive regulation of translational initiation (GO:0045948) | 4.10356349 |
| 28 | positive regulation of T cell apoptotic process (GO:0070234) | 4.07241825 |
| 29 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 4.01254670 |
| 30 | regulation of gamma-delta T cell activation (GO:0046643) | 4.01004809 |
| 31 | negative regulation of execution phase of apoptosis (GO:1900118) | 4.00914443 |
| 32 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.00192058 |
| 33 | regulation of T cell receptor signaling pathway (GO:0050856) | 3.94460899 |
| 34 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.90630278 |
| 35 | regulation of B cell differentiation (GO:0045577) | 3.89420098 |
| 36 | RNA localization (GO:0006403) | 3.82180822 |
| 37 | regulation of viral genome replication (GO:0045069) | 3.70733412 |
| 38 | lipoxygenase pathway (GO:0019372) | 3.67661434 |
| 39 | negative T cell selection (GO:0043383) | 3.66680120 |
| 40 | chemokine-mediated signaling pathway (GO:0070098) | 3.61755330 |
| 41 | negative regulation of viral process (GO:0048525) | 3.59705155 |
| 42 | positive regulation of interleukin-1 beta secretion (GO:0050718) | 3.57320228 |
| 43 | positive thymic T cell selection (GO:0045059) | 3.45115920 |
| 44 | iron-sulfur cluster assembly (GO:0016226) | 3.43737576 |
| 45 | metallo-sulfur cluster assembly (GO:0031163) | 3.43737576 |
| 46 | pyrimidine-containing compound catabolic process (GO:0072529) | 3.41015806 |
| 47 | positive T cell selection (GO:0043368) | 3.39239496 |
| 48 | leukocyte degranulation (GO:0043299) | 3.38695989 |
| 49 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.37511300 |
| 50 | positive regulation of interleukin-1 secretion (GO:0050716) | 3.36850462 |
| 51 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.33650715 |
| 52 | regulation of interleukin-1 beta secretion (GO:0050706) | 3.26468278 |
| 53 | thymic T cell selection (GO:0045061) | 3.23544734 |
| 54 | positive regulation of lymphocyte migration (GO:2000403) | 3.22178743 |
| 55 | regulation of execution phase of apoptosis (GO:1900117) | 3.16884150 |
| 56 | positive regulation of interleukin-8 secretion (GO:2000484) | 3.16301485 |
| 57 | platelet formation (GO:0030220) | 3.15885724 |
| 58 | secretory granule organization (GO:0033363) | 3.15803273 |
| 59 | positive regulation of signal transduction by p53 class mediator (GO:1901798) | 3.15628081 |
| 60 | negative regulation of viral transcription (GO:0032897) | 3.15411201 |
| 61 | response to interferon-beta (GO:0035456) | 3.15172779 |
| 62 | negative thymic T cell selection (GO:0045060) | 3.13664044 |
| 63 | T cell selection (GO:0045058) | 3.12599759 |
| 64 | negative regulation of cell killing (GO:0031342) | 3.09313010 |
| 65 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 3.09313010 |
| 66 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class | 3.08791897 |
| 67 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.08412688 |
| 68 | positive regulation of T cell cytokine production (GO:0002726) | 3.07593490 |
| 69 | T cell costimulation (GO:0031295) | 3.04555337 |
| 70 | lymphocyte costimulation (GO:0031294) | 3.00453946 |
| 71 | neutrophil activation (GO:0042119) | 3.00163803 |
| 72 | positive regulation of lymphocyte apoptotic process (GO:0070230) | 2.96213576 |
| 73 | protein kinase B signaling (GO:0043491) | 2.94865694 |
| 74 | regulation of calcium-mediated signaling (GO:0050848) | 2.92792091 |
| 75 | regulation of chemokine biosynthetic process (GO:0045073) | 2.92787768 |
| 76 | monocyte chemotaxis (GO:0002548) | 2.91238612 |
| 77 | regulation of interleukin-1 secretion (GO:0050704) | 2.89294707 |
| 78 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.88248789 |
| 79 | positive regulation of acute inflammatory response (GO:0002675) | 2.87784552 |
| 80 | interferon-gamma production (GO:0032609) | 2.87500300 |
| 81 | positive regulation of cAMP-mediated signaling (GO:0043950) | 2.86420961 |
| 82 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 2.86002291 |
| 83 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.84204313 |
| 84 | negative regulation of bone mineralization (GO:0030502) | 2.82428516 |
| 85 | cellular response to zinc ion (GO:0071294) | 2.81195071 |
| 86 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.80468323 |
| 87 | regulation of chronic inflammatory response (GO:0002676) | 2.78037001 |
| 88 | regulation of immunoglobulin secretion (GO:0051023) | 2.77338049 |
| 89 | positive regulation of leukocyte apoptotic process (GO:2000108) | 2.76731235 |
| 90 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.76331107 |
| 91 | leukocyte aggregation (GO:0070486) | 2.76008939 |
| 92 | regulation of activation of Janus kinase activity (GO:0010533) | 2.75223966 |
| 93 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.74512583 |
| 94 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.73823564 |
| 95 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 2.73585671 |
| 96 | positive regulation of interleukin-1 beta production (GO:0032731) | 2.73284243 |
| 97 | cytidine deamination (GO:0009972) | 12.5103390 |
| 98 | cytidine metabolic process (GO:0046087) | 12.5103390 |
| 99 | cytidine catabolic process (GO:0006216) | 12.5103390 |
| 100 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 11.4851192 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 6.83384997 |
| 2 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 4.94342237 |
| 3 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 4.82707256 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.81246789 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.30803498 |
| 6 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.89541667 |
| 7 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 3.83864370 |
| 8 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 3.40931450 |
| 9 | MYB_26560356_Chip-Seq_TH2_Human | 3.40791780 |
| 10 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 3.31177799 |
| 11 | RUNX_20019798_ChIP-Seq_JUKART_Human | 2.96932470 |
| 12 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.94063805 |
| 13 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.86166091 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.60823793 |
| 15 | UTX_26944678_Chip-Seq_JUKART_Human | 2.57359957 |
| 16 | MYB_26560356_Chip-Seq_TH1_Human | 2.50891972 |
| 17 | MAF_26560356_Chip-Seq_TH1_Human | 2.50623324 |
| 18 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.43106970 |
| 19 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.39183545 |
| 20 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.33032998 |
| 21 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.27086897 |
| 22 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.22883077 |
| 23 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.18542471 |
| 24 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.16005356 |
| 25 | CIITA_25753668_ChIP-Seq_RAJI_Human | 2.15944354 |
| 26 | GATA3_26560356_Chip-Seq_TH2_Human | 2.14473037 |
| 27 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.12873319 |
| 28 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.11672182 |
| 29 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 2.11554081 |
| 30 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.09783278 |
| 31 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.94635485 |
| 32 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.87958869 |
| 33 | MAF_26560356_Chip-Seq_TH2_Human | 1.86497584 |
| 34 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.82146111 |
| 35 | SPI1_23127762_ChIP-Seq_K562_Human | 1.77157886 |
| 36 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.75989725 |
| 37 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.71069353 |
| 38 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.37558544 |
| 39 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.36421696 |
| 40 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.33916643 |
| 41 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.31586335 |
| 42 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.25608509 |
| 43 | MYC_22102868_ChIP-Seq_BL_Human | 1.24294226 |
| 44 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.23338893 |
| 45 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.23268152 |
| 46 | YY1_22570637_ChIP-Seq_MALME-3M_Human | 1.16227918 |
| 47 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.15660830 |
| 48 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.14194835 |
| 49 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.09131992 |
| 50 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.08758520 |
| 51 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.07775737 |
| 52 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.06271352 |
| 53 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.05736555 |
| 54 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.04834540 |
| 55 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.03566886 |
| 56 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.00920705 |
| 57 | SCL_19346495_ChIP-Seq_HPC-7_Human | 0.99386478 |
| 58 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.99331155 |
| 59 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.98454543 |
| 60 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.97703749 |
| 61 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.96069555 |
| 62 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.95768010 |
| 63 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.94868803 |
| 64 | * CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 0.92935260 |
| 65 | TAF2_19829295_ChIP-Seq_ESCs_Human | 0.92563671 |
| 66 | GATA3_26560356_Chip-Seq_TH1_Human | 0.90764422 |
| 67 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 0.90662196 |
| 68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 0.90271979 |
| 69 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 0.89509684 |
| 70 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.89487193 |
| 71 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 0.89398608 |
| 72 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.88594989 |
| 73 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.87278785 |
| 74 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.86200377 |
| 75 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.85902118 |
| 76 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.85404626 |
| 77 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.85174825 |
| 78 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 0.84632823 |
| 79 | FOXP3_21729870_ChIP-Seq_TREG_Human | 0.84102120 |
| 80 | P300_27268052_Chip-Seq_Bcells_Human | 0.83097692 |
| 81 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.81946467 |
| 82 | WDR5_24793694_ChIP-Seq_LNCAP_Human | 0.81326133 |
| 83 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.80396082 |
| 84 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.80293119 |
| 85 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.79672678 |
| 86 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.78451787 |
| 87 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.78413595 |
| 88 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.77996097 |
| 89 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.77587728 |
| 90 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.75423082 |
| 91 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.74981950 |
| 92 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.74328885 |
| 93 | CTCF_26484167_Chip-Seq_Bcells_Mouse | 0.73578198 |
| 94 | SA1_27219007_Chip-Seq_Bcells_Human | 0.72852633 |
| 95 | TP53_16413492_ChIP-PET_HCT116_Human | 0.71860167 |
| 96 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.70141049 |
| 97 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.68860830 |
| 98 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.68481499 |
| 99 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 0.68274572 |
| 100 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.67278543 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005671_abnormal_response_to | 6.29585917 |
| 2 | MP0003436_decreased_susceptibility_to | 4.60738755 |
| 3 | MP0006082_CNS_inflammation | 4.34345442 |
| 4 | MP0009785_altered_susceptibility_to | 3.89683089 |
| 5 | MP0003045_fibrosis | 3.64785688 |
| 6 | MP0003763_abnormal_thymus_physiology | 3.37382561 |
| 7 | MP0005000_abnormal_immune_tolerance | 3.31899667 |
| 8 | MP0005387_immune_system_phenotype | 3.05441898 |
| 9 | MP0001790_abnormal_immune_system | 3.05441898 |
| 10 | MP0009333_abnormal_splenocyte_physiolog | 3.01968140 |
| 11 | MP0001835_abnormal_antigen_presentation | 3.00004117 |
| 12 | MP0005025_abnormal_response_to | 2.87517884 |
| 13 | MP0002148_abnormal_hypersensitivity_rea | 2.83621453 |
| 14 | MP0001800_abnormal_humoral_immune | 2.79924549 |
| 15 | MP0000685_abnormal_immune_system | 2.77314524 |
| 16 | MP0002420_abnormal_adaptive_immunity | 2.58086747 |
| 17 | MP0002723_abnormal_immune_serum | 2.57989606 |
| 18 | MP0001819_abnormal_immune_cell | 2.56615284 |
| 19 | MP0002132_abnormal_respiratory_system | 2.37320123 |
| 20 | MP0002398_abnormal_bone_marrow | 2.14032390 |
| 21 | MP0002405_respiratory_system_inflammati | 2.14014777 |
| 22 | MP0002452_abnormal_antigen_presenting | 2.13056559 |
| 23 | MP0002419_abnormal_innate_immunity | 2.12616829 |
| 24 | MP0005377_hearing/vestibular/ear_phenot | 2.10723147 |
| 25 | MP0003878_abnormal_ear_physiology | 2.10723147 |
| 26 | MP0000703_abnormal_thymus_morphology | 1.99785771 |
| 27 | MP0003646_muscle_fatigue | 1.93638998 |
| 28 | MP0000716_abnormal_immune_system | 1.88915830 |
| 29 | MP0010155_abnormal_intestine_physiology | 1.84200789 |
| 30 | MP0003448_altered_tumor_morphology | 1.81268306 |
| 31 | MP0001533_abnormal_skeleton_physiology | 1.80778068 |
| 32 | MP0002722_abnormal_immune_system | 1.80313513 |
| 33 | MP0002877_abnormal_melanocyte_morpholog | 1.79952923 |
| 34 | MP0004947_skin_inflammation | 1.76978898 |
| 35 | MP0001845_abnormal_inflammatory_respons | 1.73865885 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.58423286 |
| 37 | MP0003724_increased_susceptibility_to | 1.55365148 |
| 38 | MP0003252_abnormal_bile_duct | 1.54974626 |
| 39 | MP0003866_abnormal_defecation | 1.48824526 |
| 40 | MP0009764_decreased_sensitivity_to | 1.48503765 |
| 41 | MP0002429_abnormal_blood_cell | 1.48217592 |
| 42 | MP0002168_other_aberrant_phenotype | 1.46293110 |
| 43 | MP0002277_abnormal_respiratory_mucosa | 1.45099034 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 1.41633342 |
| 45 | MP0005083_abnormal_biliary_tract | 1.41319934 |
| 46 | MP0001485_abnormal_pinna_reflex | 1.38634714 |
| 47 | MP0003279_aneurysm | 1.29858493 |
| 48 | MP0004510_myositis | 1.27531401 |
| 49 | MP0001958_emphysema | 1.23274881 |
| 50 | MP0002933_joint_inflammation | 1.17812771 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.17626712 |
| 52 | MP0008260_abnormal_autophagy | 1.16928255 |
| 53 | MP0003806_abnormal_nucleotide_metabolis | 1.15770080 |
| 54 | MP0008469_abnormal_protein_level | 1.15115609 |
| 55 | MP0005464_abnormal_platelet_physiology | 1.10481285 |
| 56 | MP0006054_spinal_hemorrhage | 1.08453727 |
| 57 | MP0002138_abnormal_hepatobiliary_system | 1.02110289 |
| 58 | MP0009763_increased_sensitivity_to | 0.99327503 |
| 59 | MP0009765_abnormal_xenobiotic_induced | 0.95383257 |
| 60 | MP0002102_abnormal_ear_morphology | 0.92640619 |
| 61 | MP0006036_abnormal_mitochondrial_physio | 0.91523795 |
| 62 | MP0001501_abnormal_sleep_pattern | 0.86702721 |
| 63 | MP0000569_abnormal_digit_pigmentation | 0.86130598 |
| 64 | MP0002136_abnormal_kidney_physiology | 0.83371680 |
| 65 | MP0000858_altered_metastatic_potential | 0.78109530 |
| 66 | MP0002163_abnormal_gland_morphology | 0.77384208 |
| 67 | MP0002019_abnormal_tumor_incidence | 0.73537987 |
| 68 | MP0003195_calcinosis | 0.73442144 |
| 69 | MP0002254_reproductive_system_inflammat | 0.70484519 |
| 70 | MP0001873_stomach_inflammation | 0.70150770 |
| 71 | MP0001188_hyperpigmentation | 0.68955095 |
| 72 | MP0005310_abnormal_salivary_gland | 0.62469156 |
| 73 | MP0002876_abnormal_thyroid_physiology | 0.60598547 |
| 74 | MP0003567_abnormal_fetal_cardiomyocyte | 0.59277777 |
| 75 | MP0002396_abnormal_hematopoietic_system | 0.59047879 |
| 76 | MP0005166_decreased_susceptibility_to | 0.58793961 |
| 77 | MP0005410_abnormal_fertilization | 0.58513773 |
| 78 | MP0001849_ear_inflammation | 0.56551702 |
| 79 | MP0003137_abnormal_impulse_conducting | 0.54723349 |
| 80 | MP0001348_abnormal_lacrimal_gland | 0.54463115 |
| 81 | MP0005395_other_phenotype | 0.54431457 |
| 82 | MP0005390_skeleton_phenotype | 0.53571180 |
| 83 | MP0001486_abnormal_startle_reflex | 0.50598429 |
| 84 | MP0000358_abnormal_cell_content/ | 0.49789266 |
| 85 | MP0009046_muscle_twitch | 0.48102143 |
| 86 | MP0002693_abnormal_pancreas_physiology | 0.47972145 |
| 87 | MP0003950_abnormal_plasma_membrane | 0.46534055 |
| 88 | MP0002928_abnormal_bile_duct | 0.45973548 |
| 89 | MP0002998_abnormal_bone_remodeling | 0.45480272 |
| 90 | MP0001851_eye_inflammation | 0.45182980 |
| 91 | MP0002332_abnormal_exercise_endurance | 0.44935973 |
| 92 | MP0000678_abnormal_parathyroid_gland | 0.43337079 |
| 93 | MP0001986_abnormal_taste_sensitivity | 0.43130750 |
| 94 | MP0003786_premature_aging | 0.42643828 |
| 95 | MP0005623_abnormal_meninges_morphology | 0.40904016 |
| 96 | MP0001919_abnormal_reproductive_system | 0.40468204 |
| 97 | MP0005332_abnormal_amino_acid | 0.40334451 |
| 98 | MP0009643_abnormal_urine_homeostasis | 0.39673520 |
| 99 | MP0003303_peritoneal_inflammation | 0.36739249 |
| 100 | MP0005075_abnormal_melanosome_morpholog | 0.35882817 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Stomatitis (HP:0010280) | 9.47349233 |
| 2 | Autoimmune hemolytic anemia (HP:0001890) | 7.44363722 |
| 3 | Increased IgM level (HP:0003496) | 5.90414152 |
| 4 | Abnormality of T cell number (HP:0011839) | 5.50089711 |
| 5 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 5.47840271 |
| 6 | T lymphocytopenia (HP:0005403) | 5.20118389 |
| 7 | Abnormality of T cells (HP:0002843) | 4.91323248 |
| 8 | Recurrent abscess formation (HP:0002722) | 4.65795376 |
| 9 | Abnormality of T cell physiology (HP:0011840) | 4.52885952 |
| 10 | Mediastinal lymphadenopathy (HP:0100721) | 3.99260414 |
| 11 | Autoimmune thrombocytopenia (HP:0001973) | 3.90381774 |
| 12 | Severe combined immunodeficiency (HP:0004430) | 3.86527886 |
| 13 | Facial diplegia (HP:0001349) | 3.81975453 |
| 14 | Orchitis (HP:0100796) | 3.81064039 |
| 15 | Obstructive lung disease (HP:0006536) | 3.80727892 |
| 16 | Chronic obstructive pulmonary disease (HP:0006510) | 3.80727892 |
| 17 | Meningitis (HP:0001287) | 3.71589373 |
| 18 | Myositis (HP:0100614) | 3.70300133 |
| 19 | Gingivitis (HP:0000230) | 3.69850274 |
| 20 | Gastrointestinal infarctions (HP:0005244) | 3.58947426 |
| 21 | IgM deficiency (HP:0002850) | 3.45427788 |
| 22 | Eosinophilia (HP:0001880) | 3.39313041 |
| 23 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.31247456 |
| 24 | IgG deficiency (HP:0004315) | 3.22981875 |
| 25 | Abnormality of eosinophils (HP:0001879) | 3.21441803 |
| 26 | Retrobulbar optic neuritis (HP:0100654) | 3.19868756 |
| 27 | Optic neuritis (HP:0100653) | 3.19868756 |
| 28 | Panhypogammaglobulinemia (HP:0003139) | 3.12658510 |
| 29 | Combined immunodeficiency (HP:0005387) | 3.10563840 |
| 30 | Progressive inability to walk (HP:0002505) | 3.08303991 |
| 31 | Abnormality of macrophages (HP:0004311) | 3.04622743 |
| 32 | Granulocytopenia (HP:0001913) | 3.02419921 |
| 33 | Leukocytosis (HP:0001974) | 3.00575083 |
| 34 | Encephalitis (HP:0002383) | 2.93578715 |
| 35 | Hypergammaglobulinemia (HP:0010702) | 2.88577450 |
| 36 | Vasculitis (HP:0002633) | 2.83673840 |
| 37 | Eczematoid dermatitis (HP:0000976) | 2.82086643 |
| 38 | Cutaneous melanoma (HP:0012056) | 2.81430484 |
| 39 | Abnormality of B cell number (HP:0010975) | 2.66432206 |
| 40 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.64368691 |
| 41 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.64368691 |
| 42 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.63897664 |
| 43 | Recurrent cutaneous fungal infections (HP:0011370) | 2.63897664 |
| 44 | Recurrent fungal infections (HP:0002841) | 2.61378381 |
| 45 | Dry hair (HP:0011359) | 2.60975497 |
| 46 | Acute hepatic failure (HP:0006554) | 2.56311969 |
| 47 | Ileus (HP:0002595) | 2.52301500 |
| 48 | Chest pain (HP:0100749) | 2.49285583 |
| 49 | Recurrent bronchitis (HP:0002837) | 2.48526349 |
| 50 | Reticulocytosis (HP:0001923) | 2.47669161 |
| 51 | Joint swelling (HP:0001386) | 2.47448423 |
| 52 | Thyroiditis (HP:0100646) | 2.45838281 |
| 53 | Hypoproteinemia (HP:0003075) | 2.42591871 |
| 54 | Recurrent bacterial skin infections (HP:0005406) | 2.39244545 |
| 55 | Urticaria (HP:0001025) | 2.33889756 |
| 56 | Pulmonary infiltrates (HP:0002113) | 2.22545623 |
| 57 | Keratoconjunctivitis sicca (HP:0001097) | 2.20571902 |
| 58 | Type I transferrin isoform profile (HP:0003642) | 2.18632158 |
| 59 | Premature loss of primary teeth (HP:0006323) | 2.17970396 |
| 60 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.17414016 |
| 61 | Alveolar cell carcinoma (HP:0006519) | 2.16028578 |
| 62 | Increased IgE level (HP:0003212) | 2.15460927 |
| 63 | Gastrointestinal dysmotility (HP:0002579) | 2.13304076 |
| 64 | Pustule (HP:0200039) | 2.12419357 |
| 65 | Recurrent sinusitis (HP:0011108) | 2.12404944 |
| 66 | Abnormality of oral frenula (HP:0000190) | 2.09211749 |
| 67 | Recurrent viral infections (HP:0004429) | 2.06954476 |
| 68 | Decreased lacrimation (HP:0000633) | 2.06636579 |
| 69 | Abnormal platelet function (HP:0011869) | 2.05595908 |
| 70 | Impaired platelet aggregation (HP:0003540) | 2.05595908 |
| 71 | Arterial thrombosis (HP:0004420) | 2.02358968 |
| 72 | Hypoplasia of the thymus (HP:0000778) | 2.02184907 |
| 73 | Keratoconjunctivitis (HP:0001096) | 2.01436835 |
| 74 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.01200847 |
| 75 | Anorexia (HP:0002039) | 2.00226177 |
| 76 | Chronic diarrhea (HP:0002028) | 1.98970643 |
| 77 | Premature graying of hair (HP:0002216) | 1.97653713 |
| 78 | Agammaglobulinemia (HP:0004432) | 1.97577076 |
| 79 | IgA deficiency (HP:0002720) | 1.97071546 |
| 80 | Hemoptysis (HP:0002105) | 1.95702715 |
| 81 | Gangrene (HP:0100758) | 1.95346216 |
| 82 | Recurrent skin infections (HP:0001581) | 1.95004839 |
| 83 | Lymphopenia (HP:0001888) | 1.94397389 |
| 84 | Abnormal auditory evoked potentials (HP:0006958) | 1.91691859 |
| 85 | Conjugated hyperbilirubinemia (HP:0002908) | 1.89431341 |
| 86 | Amyotrophic lateral sclerosis (HP:0007354) | 1.87088639 |
| 87 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.86650396 |
| 88 | Vacuolated lymphocytes (HP:0001922) | 1.84095686 |
| 89 | Cerebral hypomyelination (HP:0006808) | 1.82926567 |
| 90 | B lymphocytopenia (HP:0010976) | 1.81417493 |
| 91 | Delusions (HP:0000746) | 1.80187930 |
| 92 | Hypochromic anemia (HP:0001931) | 1.77580933 |
| 93 | Sepsis (HP:0100806) | 1.76737520 |
| 94 | Peritonitis (HP:0002586) | 1.74794591 |
| 95 | Poor speech (HP:0002465) | 1.74067072 |
| 96 | Hypertensive crisis (HP:0100735) | 1.74003577 |
| 97 | Retinopathy (HP:0000488) | 1.72002240 |
| 98 | Lymphoma (HP:0002665) | 1.71314393 |
| 99 | Polyneuropathy (HP:0001271) | 1.70627528 |
| 100 | Episodic fever (HP:0001954) | 1.69805300 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK1 | 6.24016268 |
| 2 | MAP3K12 | 4.19994356 |
| 3 | MAP4K1 | 4.16620558 |
| 4 | KDR | 3.98810869 |
| 5 | TXK | 3.91337181 |
| 6 | MAP3K11 | 3.85072557 |
| 7 | TESK2 | 3.82373445 |
| 8 | MAPKAPK3 | 3.56859588 |
| 9 | BLK | 3.06108460 |
| 10 | BMPR2 | 2.56033043 |
| 11 | CSK | 2.13034934 |
| 12 | CLK1 | 2.08418707 |
| 13 | CDK3 | 2.01280874 |
| 14 | FES | 2.00127212 |
| 15 | ERN1 | 1.87718824 |
| 16 | PRKCI | 1.86622492 |
| 17 | TESK1 | 1.75878344 |
| 18 | SYK | 1.67267683 |
| 19 | ZAP70 | 1.65369109 |
| 20 | IRAK4 | 1.54751855 |
| 21 | JAK3 | 1.54035637 |
| 22 | PRKCG | 1.45267229 |
| 23 | ITK | 1.40229455 |
| 24 | RIPK4 | 1.30913497 |
| 25 | DAPK1 | 1.29528419 |
| 26 | MAP3K5 | 1.29012709 |
| 27 | FGR | 1.28192858 |
| 28 | ACVR1B | 1.27627707 |
| 29 | MST4 | 1.19863295 |
| 30 | BTK | 1.15949116 |
| 31 | PIK3CA | 1.15865520 |
| 32 | PRKCQ | 1.14998516 |
| 33 | IKBKB | 1.13135551 |
| 34 | LYN | 1.12478535 |
| 35 | LCK | 1.10680394 |
| 36 | GRK6 | 0.99720294 |
| 37 | EPHB1 | 0.99238789 |
| 38 | PRKCE | 0.94931257 |
| 39 | FYN | 0.91346987 |
| 40 | CSF1R | 0.90975813 |
| 41 | PDPK1 | 0.83588236 |
| 42 | TAOK3 | 0.82368418 |
| 43 | LIMK1 | 0.81572084 |
| 44 | MAP3K1 | 0.78726217 |
| 45 | PTK6 | 0.78236312 |
| 46 | STK10 | 0.77825791 |
| 47 | MAP3K13 | 0.73786635 |
| 48 | FGFR1 | 0.68753487 |
| 49 | TEC | 0.65477182 |
| 50 | IKBKE | 0.65202898 |
| 51 | HCK | 0.63231005 |
| 52 | DAPK3 | 0.61366004 |
| 53 | PRKCD | 0.61197054 |
| 54 | FGFR2 | 0.58031072 |
| 55 | FGFR4 | 0.57645521 |
| 56 | PAK6 | 0.54760111 |
| 57 | ALK | 0.51196682 |
| 58 | GRK7 | 0.49468428 |
| 59 | KIT | 0.47693797 |
| 60 | JAK1 | 0.47580816 |
| 61 | BUB1 | 0.46377460 |
| 62 | TAOK1 | 0.44927592 |
| 63 | IGF1R | 0.42645266 |
| 64 | MAP2K7 | 0.42601382 |
| 65 | TGFBR2 | 0.42146265 |
| 66 | PRKCZ | 0.39009231 |
| 67 | CSNK1D | 0.36154659 |
| 68 | MAP3K10 | 0.35531100 |
| 69 | PRKCB | 0.35027035 |
| 70 | IRAK1 | 0.34082264 |
| 71 | FGFR3 | 0.33435766 |
| 72 | YES1 | 0.33235223 |
| 73 | PRKCA | 0.32964435 |
| 74 | MARK2 | 0.32211017 |
| 75 | MAP3K7 | 0.30365707 |
| 76 | SRC | 0.28132088 |
| 77 | PRKCH | 0.27007047 |
| 78 | MYLK | 0.26894367 |
| 79 | PRKD1 | 0.25867073 |
| 80 | MOS | 0.25122369 |
| 81 | TNK2 | 0.24622358 |
| 82 | MAP2K6 | 0.24429894 |
| 83 | KSR2 | 0.24295521 |
| 84 | RPS6KA5 | 0.23608527 |
| 85 | ILK | 0.22702252 |
| 86 | TRIB3 | 0.22570658 |
| 87 | JAK2 | 0.21889277 |
| 88 | RET | 0.21183489 |
| 89 | TBK1 | 0.21098549 |
| 90 | CHUK | 0.19208388 |
| 91 | MAP2K4 | 0.18476308 |
| 92 | GRK5 | 0.18015654 |
| 93 | FRK | 0.15641479 |
| 94 | CSNK2A1 | 0.15595542 |
| 95 | MAPKAPK2 | 0.15517702 |
| 96 | ROCK1 | 0.14707826 |
| 97 | BCR | 0.14075572 |
| 98 | PDK1 | 0.13916584 |
| 99 | INSR | 0.13153770 |
| 100 | ADRBK2 | 0.10388315 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Graft-versus-host disease_Homo sapiens_hsa05332 | 5.41630284 |
| 2 | Primary immunodeficiency_Homo sapiens_hsa05340 | 4.54859453 |
| 3 | * Antigen processing and presentation_Homo sapiens_hsa04612 | 4.19817714 |
| 4 | * Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.89287091 |
| 5 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.02390542 |
| 6 | Proteasome_Homo sapiens_hsa03050 | 3.00827954 |
| 7 | Allograft rejection_Homo sapiens_hsa05330 | 2.99936190 |
| 8 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.85562839 |
| 9 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 2.72372042 |
| 10 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.42279510 |
| 11 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 2.19807287 |
| 12 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.90781173 |
| 13 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.85640452 |
| 14 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.85170353 |
| 15 | Measles_Homo sapiens_hsa05162 | 1.74949266 |
| 16 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.71475897 |
| 17 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.68545462 |
| 18 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66392277 |
| 19 | Asthma_Homo sapiens_hsa05310 | 1.65032411 |
| 20 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.59566577 |
| 21 | Leishmaniasis_Homo sapiens_hsa05140 | 1.58392087 |
| 22 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.55845285 |
| 23 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.47747196 |
| 24 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.46267172 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.40916776 |
| 26 | Shigellosis_Homo sapiens_hsa05131 | 1.40043369 |
| 27 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.39294125 |
| 28 | Malaria_Homo sapiens_hsa05144 | 1.36969524 |
| 29 | Viral myocarditis_Homo sapiens_hsa05416 | 1.34314154 |
| 30 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.28995838 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.27980131 |
| 32 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.27077253 |
| 33 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.15487268 |
| 34 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.10001548 |
| 35 | Parkinsons disease_Homo sapiens_hsa05012 | 1.02692988 |
| 36 | Salmonella infection_Homo sapiens_hsa05132 | 1.01926641 |
| 37 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.98457208 |
| 38 | Tuberculosis_Homo sapiens_hsa05152 | 0.95031514 |
| 39 | Mineral absorption_Homo sapiens_hsa04978 | 0.91122872 |
| 40 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.89942001 |
| 41 | Pertussis_Homo sapiens_hsa05133 | 0.89410563 |
| 42 | Legionellosis_Homo sapiens_hsa05134 | 0.83357250 |
| 43 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.80464136 |
| 44 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.80399389 |
| 45 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.80009803 |
| 46 | Alzheimers disease_Homo sapiens_hsa05010 | 0.77232714 |
| 47 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.77082817 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.73525708 |
| 49 | Apoptosis_Homo sapiens_hsa04210 | 0.73366071 |
| 50 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.71754557 |
| 51 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.63762985 |
| 52 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60886583 |
| 53 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57580966 |
| 54 | Influenza A_Homo sapiens_hsa05164 | 0.57569485 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.57550924 |
| 56 | Peroxisome_Homo sapiens_hsa04146 | 0.57385251 |
| 57 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.56822538 |
| 58 | Hepatitis C_Homo sapiens_hsa05160 | 0.56146395 |
| 59 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54661862 |
| 60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.52916079 |
| 61 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.52404968 |
| 62 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.48517421 |
| 63 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.46632080 |
| 64 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45373614 |
| 65 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.44141093 |
| 66 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.43788764 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.42017751 |
| 68 | Olfactory transduction_Homo sapiens_hsa04740 | 0.42000844 |
| 69 | Endocytosis_Homo sapiens_hsa04144 | 0.40682916 |
| 70 | ABC transporters_Homo sapiens_hsa02010 | 0.40019206 |
| 71 | Phototransduction_Homo sapiens_hsa04744 | 0.38232368 |
| 72 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.37688765 |
| 73 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.35656304 |
| 74 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.34779481 |
| 75 | HTLV-I infection_Homo sapiens_hsa05166 | 0.34385745 |
| 76 | Phagosome_Homo sapiens_hsa04145 | 0.33537845 |
| 77 | Insulin resistance_Homo sapiens_hsa04931 | 0.32880242 |
| 78 | Galactose metabolism_Homo sapiens_hsa00052 | 0.32812943 |
| 79 | Hepatitis B_Homo sapiens_hsa05161 | 0.31921193 |
| 80 | Sulfur relay system_Homo sapiens_hsa04122 | 0.29563475 |
| 81 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.28910575 |
| 82 | Huntingtons disease_Homo sapiens_hsa05016 | 0.27613931 |
| 83 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.27255359 |
| 84 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.25386765 |
| 85 | Platelet activation_Homo sapiens_hsa04611 | 0.23412140 |
| 86 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.22837822 |
| 87 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.21814031 |
| 88 | Lysosome_Homo sapiens_hsa04142 | 0.21371198 |
| 89 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.20463387 |
| 90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.17966707 |
| 91 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.17924650 |
| 92 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16788687 |
| 93 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.15389893 |
| 94 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.15120935 |
| 95 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.14356424 |
| 96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.13577110 |
| 97 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.13064697 |
| 98 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.12054312 |
| 99 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.11281372 |
| 100 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.11081987 |

